Literature DB >> 23144577

Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?

I Kuchuk1, M Clemons, C Addison.   

Abstract

Entities:  

Year:  2012        PMID： 23144577      PMCID： PMC3457880          DOI： 10.3747/co.19.1009

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  4 in total

Review 1.  Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists.

Authors:  Nathaniel Bouganim; George Dranitsaris; Eitan Amir; Mark Clemons
Journal:  Support Care Cancer       Date:  2011-07-22       Impact factor: 3.603

2.  Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.

Authors:  Alison T Stopeck; Allan Lipton; Jean-Jacques Body; Guenther G Steger; Katia Tonkin; Richard H de Boer; Mikhail Lichinitser; Yasuhiro Fujiwara; Denise A Yardley; María Viniegra; Michelle Fan; Qi Jiang; Roger Dansey; Susie Jun; Ada Braun
Journal:  J Clin Oncol       Date:  2010-11-08       Impact factor: 44.544

Review 3.  Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.

Authors:  L Costa
Journal:  Breast       Date:  2007-11-26       Impact factor: 4.380

4.  Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis.

Authors:  S M Ali; L M Demers; K Leitzel; H A Harvey; D Clemens; N Mallinak; L Engle; V Chinchilli; L Costa; C Brady; J Seaman; A Lipton
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976
  4 in total
  13 in total

Review 1.  Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines.

Authors:  A A Joy; M Ghosh; R Fernandes; M J Clemons
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

2.  Publishing clinical research: ten pearls for oncology trainees and junior oncologists.

Authors:  S Mazzarello; M Clemons; C Jacobs; A Arnaout; M Fralick
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

3.  A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

Authors:  Christina L Addison; Nathaniel Bouganim; John Hilton; Lisa Vandermeer; Susan Dent; Eitan Amir; Sean Hopkins; Iryna Kuchuk; Roanne Segal; Xinni Song; Stan Gertler; Sasha Mazzarello; George Dranitsaris; Daylily Ooi; Gregory Pond; Mark Clemons
Journal:  Breast Cancer Res Treat       Date:  2014-03-18       Impact factor: 4.872

4.  Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey.

Authors:  Brian Hutton; Patricia Morretto; Urban Emmenegger; Sasha Mazzarello; Iryna Kuchuk; Christina L Addison; Freya Crawley; Christine Canil; Shawn Malone; Scott Berry; Dean Fergusson; Mark Clemons
Journal:  J Bone Oncol       Date:  2013-06-21       Impact factor: 4.072

5.  De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists.

Authors:  Brian Hutton; Christina Addison; Sasha Mazzarello; Anil A Joy; Nathaniel Bouganim; Dean Fergusson; Mark Clemons
Journal:  J Bone Oncol       Date:  2013-04-15       Impact factor: 4.072

Review 6.  A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer.

Authors:  Brian Hutton; Christina L Addison; Kaitryn Campbell; Dean Fergusson; Sasha Mazarello; Mark Clemons
Journal:  J Bone Oncol       Date:  2013-05-15       Impact factor: 4.072

7.  Incidence, consequences and treatment of bone metastases in breast cancer patients-Experience from a single cancer centre.

Authors:  I Kuchuk; B Hutton; P Moretto; T Ng; C L Addison; M Clemons
Journal:  J Bone Oncol       Date:  2013-10-03       Impact factor: 4.072

Review 8.  Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS).

Authors:  Ricardo Fernandes; Peter Siegel; Svetlana Komarova; John Hilton; Christina Addison; Mohammed F K Ibrahim; Joel Werier; Kristopher Dennis; Gurmit Singh; Eitan Amir; Virginia Jarvis; Urban Emmenegger; Sasha Mazzarello; Mark Clemons
Journal:  J Bone Oncol       Date:  2016-02-23       Impact factor: 4.072

9.  Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meeting.

Authors:  Xiaofu Zhu; Eitan Amir; Gurmit Singh; Mark Clemons; Christina Addison
Journal:  J Bone Oncol       Date:  2014-02-04       Impact factor: 4.072

Review 10.  Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases.

Authors:  Demetrios Simos; Christina L Addison; Iryna Kuchuk; Brian Hutton; Sasha Mazzarello; Mark Clemons
Journal:  J Clin Med       Date:  2013-08-19       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.